Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Invernizzi

Showing results (161-170 of 215) with videos related to

Pageof 22
Sort By:
Eye (London, England)|April 2, 2026
Defining a standards framework for ophthalmology real-world data methodologies through an expert-led Delphi consensusPierre-Henry Gabrielle, Francesco Bandello, Aude Couturier, et al.
Marine Drugs|February 10, 2018
Association of Alpha Tocopherol and Ag Sulfadiazine Chitosan Oleate Nanocarriers in Bioactive Dressings Supporting Platelet Lysate Application to Skin WoundsMaria Cristina Bonferoni, Giuseppina Sandri, Silvia Rossi, et al.
American Journal of Ophthalmology|April 8, 2023
Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular DegenerationFrancesco Romano, Elisa Cozzi, Matteo Airaldi, et al.
Retina (Philadelphia, Pa.)|October 12, 2023
CORRELATION BETWEEN MICROPERIMETRY AND IMAGING IN EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN-LIKE APPEARANCEFrancesco Romano, Camiel J F Boon, Alessandro Invernizzi, et al.
Scientific Reports|September 30, 2021
Retinal vessels modifications in acute and post-COVID-19Alessandro Invernizzi, Marco Schiuma, Salvatore Parrulli, et al.
Clinical & Experimental Ophthalmology|November 20, 2025
Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! RegistryTrung M Dang, Alessandro Invernizzi, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|December 28, 2024
Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! PractitionersTheodorus Ponsioen, Yohei Hashimoto, Alessandro Invernizzi, et al.
The British Journal of Ophthalmology|January 26, 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, et al.
Acta Ophthalmologica|August 18, 2019
Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implantDinah Zur, Matias Iglicki, Anna Sala-Puigdollers, et al.
Clinical & Experimental Ophthalmology|September 19, 2025
Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular DegenerationFrancesco Romano, Marco Casaluci, Antonio Valastro, et al.
Pageof 22

Showing results (161-170 of 215) with videos related to

Sort By:
Pageof 22
Eye (London, England)|April 2, 2026
Defining a standards framework for ophthalmology real-world data methodologies through an expert-led Delphi consensusPierre-Henry Gabrielle, Francesco Bandello, Aude Couturier, et al.
Marine Drugs|February 10, 2018
Association of Alpha Tocopherol and Ag Sulfadiazine Chitosan Oleate Nanocarriers in Bioactive Dressings Supporting Platelet Lysate Application to Skin WoundsMaria Cristina Bonferoni, Giuseppina Sandri, Silvia Rossi, et al.
American Journal of Ophthalmology|April 8, 2023
Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular DegenerationFrancesco Romano, Elisa Cozzi, Matteo Airaldi, et al.
Retina (Philadelphia, Pa.)|October 12, 2023
CORRELATION BETWEEN MICROPERIMETRY AND IMAGING IN EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN-LIKE APPEARANCEFrancesco Romano, Camiel J F Boon, Alessandro Invernizzi, et al.
Scientific Reports|September 30, 2021
Retinal vessels modifications in acute and post-COVID-19Alessandro Invernizzi, Marco Schiuma, Salvatore Parrulli, et al.
Clinical & Experimental Ophthalmology|November 20, 2025
Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! RegistryTrung M Dang, Alessandro Invernizzi, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|December 28, 2024
Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! PractitionersTheodorus Ponsioen, Yohei Hashimoto, Alessandro Invernizzi, et al.
The British Journal of Ophthalmology|January 26, 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, et al.
Acta Ophthalmologica|August 18, 2019
Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implantDinah Zur, Matias Iglicki, Anna Sala-Puigdollers, et al.
Clinical & Experimental Ophthalmology|September 19, 2025
Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular DegenerationFrancesco Romano, Marco Casaluci, Antonio Valastro, et al.
Pageof 22